Kenneth T. Thurn

1.7k total citations
15 papers, 1.4k citations indexed

About

Kenneth T. Thurn is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Geriatrics and Gerontology. According to data from OpenAlex, Kenneth T. Thurn has authored 15 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Geriatrics and Gerontology. Recurrent topics in Kenneth T. Thurn's work include Histone Deacetylase Inhibitors Research (9 papers), Advanced biosensing and bioanalysis techniques (5 papers) and RNA Interference and Gene Delivery (4 papers). Kenneth T. Thurn is often cited by papers focused on Histone Deacetylase Inhibitors Research (9 papers), Advanced biosensing and bioanalysis techniques (5 papers) and RNA Interference and Gene Delivery (4 papers). Kenneth T. Thurn collaborates with scholars based in United States, India and China. Kenneth T. Thurn's co-authors include Scott Thomas, Pamela N. Münster, Paromita Raha, Tatjana Paunesku, Gayle E. Woloschak, Amy P. Moore, Aiguo Wu, J. Mäser, Barry Lai and Stefan Vogt and has published in prestigious journals such as Journal of Clinical Oncology, Nano Letters and PLoS ONE.

In The Last Decade

Kenneth T. Thurn

14 papers receiving 1.3k citations

Peers

Countries citing papers authored by Kenneth T. Thurn

Since Specialization

Citations

This map shows the geographic impact of Kenneth T. Thurn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth T. Thurn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth T. Thurn more than expected).

Fields of papers citing papers by Kenneth T. Thurn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth T. Thurn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth T. Thurn. The network helps show where Kenneth T. Thurn may publish in the future.

Co-authorship network of co-authors of Kenneth T. Thurn

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth T. Thurn. A scholar is included among the top collaborators of Kenneth T. Thurn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth T. Thurn. Kenneth T. Thurn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	A phase I trial of panobinostat and epirubicin in solid tumors with a dose expansion in patients with sarcoma 2016 ·Annals of Oncology ·Scott Thomas, Rahul Aggarwal, Thierry Jahan, Charles J. Ryan, (unknown), Amy Cripps, Paromita Raha, Kenneth T. Thurn, (unknown), Jennifer A. Grabowsky, (unknown), Jimee Hwang, Adil Daud, Pamela N. Münster	24
2	Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression 2015 ·Breast Cancer Research ·Paromita Raha, Scott Thomas, Kenneth T. Thurn, (unknown), Pamela N. Münster	78
3	Histone Deacetylase Regulation of ATM-Mediated DNA Damage Signaling 2013 ·Molecular Cancer Therapeutics ·Kenneth T. Thurn, Scott Thomas, Paromita Raha, Ian Qureshi, Pamela N. Münster	92
4	Efficacy of Histone Deacetylase and Estrogen Receptor Inhibition in Breast Cancer Cells Due to Concerted down Regulation of Akt 2013 ·PLoS ONE ·Scott Thomas, Kenneth T. Thurn, Paromita Raha, Stephanie Chen, Pamela N. Münster	26
5	A phase I trial of the histone deacetylase inhibitor panobinostat (LBH589) and epirubicin in patients with solid tumor malignancies. 2012 ·Journal of Clinical Oncology ·Amy P. Moore, Thach‐Giao Truong, Kenneth T. Thurn, Scott Thomas, Charles J. Ryan, Thierry Jahan, Steven G. DuBois, John K. C. Chan, Hope S. Rugo, Eric A. Collisson, Paromita Raha, Stephanie Chen, (unknown), Adil Daud, Pamela N. Münster	1
6	Rational Therapeutic Combinations with Histone Deacetylase Inhibitors for the Treatment of Cancer 2011 ·Future Oncology ·Kenneth T. Thurn, Scott Thomas, Amy P. Moore, Pamela N. Münster	209
7	A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer 2011 ·British Journal of Cancer ·Pamela N. Münster, Kenneth T. Thurn, Scott Thomas, Paromita Raha, M. Lacevic, Alexandra Miller, Michelle Melisko, Roohi Ismail‐Khan, Hope S. Rugo, Mark M. Moasser, Susan Minton	315
8	Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy 2011 ·Breast Cancer Research and Treatment ·Scott Thomas, Kenneth T. Thurn, Elona Biçaku, Douglas C. Marchion, Pamela N. Münster	93
9	Endocytosis of titanium dioxide nanoparticles in prostate cancer PC-3M cells 2010 ·Nanomedicine Nanotechnology Biology and Medicine ·Kenneth T. Thurn, Hans Arora, Tatjana Paunesku, Aiguo Wu, Eric Brown, (unknown), Jeff C. Kremer, Gayle E. Woloschak	129
10	Labeling TiO₂ Nanoparticles with Dyes for Optical Fluorescence Microscopy and Determination of TiO₂–DNA Nanoconjugate Stability 2009 ·Small ·Kenneth T. Thurn, Tatjana Paunesku, Aiguo Wu, Eric Brown, Barry Lai, Stefan Vogt, J. Mäser, M. Aslam, Vinayak P. Dravid, Raymond C. Bergan, Gayle E. Woloschak	90
11	Abstract C1: HDAC inhibitors trigger the autophagic switch from prosurvival to prodeath in tamoxifen-treated breast cancer cells 2009 ·Molecular Cancer Therapeutics ·Scott Thomas, Kenneth T. Thurn, Ashleigh Miller, Douglas C. Marchion, Elona Biçaku, Pamela N. Münster	1
12	Gadolinium-conjugated TiO2-DNA oligonucleotide nanoconjugates show prolonged intracellular retention period and T1-weighted contrast enhancement in magnetic resonance images 2008 ·Nanomedicine Nanotechnology Biology and Medicine ·Tatjana Paunesku, (unknown), Rohan Dharmakumar, (unknown), Aiguo Wu, Barry Lai, Stefan Vogt, J. Mäser, Kenneth T. Thurn, (unknown), Andrew Larson, Raymond C. Bergan, Reed A. Omary, Debiao Li, Zheng‐Rong Lu, Gayle E. Woloschak	38
13	Methods for assessing DNA hybridization of peptide nucleic acid–titanium dioxide nanoconjugates 2008 ·Analytical Biochemistry ·Eric Brown, Tatjana Paunesku, Aiguo Wu, Kenneth T. Thurn, Benjamin Haley, J.H. Clark, (unknown), Gayle E. Woloschak	28
14	Intracellular Distribution of TiO₂−DNA Oligonucleotide Nanoconjugates Directed to Nucleolus and Mitochondria Indicates Sequence Specificity 2007 ·Nano Letters ·Tatjana Paunesku, Stefan Vogt, Barry Lai, J. Mäser, (unknown), Kenneth T. Thurn, Clodia Osipo, Hong Liu, Daniel Legnini, Zhou Wang, Chung Lee, Gayle E. Woloschak	101
15	Nanoparticles for Applications in Cellular Imaging 2007 ·Nanoscale Research Letters ·Kenneth T. Thurn, (unknown), Aiguo Wu, Stefan Vogt, Barry Lai, J. Mäser, Tatjana Paunesku, Gayle E. Woloschak	139

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact